Shukla Dhaval, Konar Subhas, Devi Bhagavatula Indira, Padmasri Gorantla, Jayanna Ranjan, Suresh Monisha, Lakshita Bhura
Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Department of Neurosurgery, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
Injury. 2023 May;54(5):1278-1286. doi: 10.1016/j.injury.2023.03.014. Epub 2023 Mar 12.
We report results of a newly developed portable near-infrared spectroscopy (NIRS) based point-of-care device CEREBO® to detect traumatic intracranial hematoma (TICH).
Patients with alleged history of head injury visiting emergency room were enrolled. They were examined consecutively for the presence of TICH using CEREBO® and computed tomography (CT) scans.
A total of 158 participants and 944 lobes were scanned, and 18% of lobes were found to have TICH on imaging with computed tomography of the head. 33.9% of the lobes could not be scanned due to scalp lacerations. The mean depth of hematoma was 0.8 (SD 0.5) cm and the mean volume of the hematoma was 7.8 (11.3) cc. The overall sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV) of CEREBO® to classify subjects as hemorrhagic or non-hemorrhagic were 96% (CI 90 - 99%), 85% (CI 73 - 93%), 92% (CI 86 - 96%), 91% (CI 84 - 96%) and 93% (CI 82 - 98%) whereas to classify the lobes as hemorrhagic and non-hemorrhagic, the sensitivity, specificity, accuracy, PPV and NPV were 93% (CI 88 - 96%), 90% (CI 87 - 92%), 90% (CI 88 - 92%), 66% (CI 61 - 73%), and 98% (CI 97 - 99%) respectively. The sensitivity was highest at 100% (CI 92 - 100%) for the detection of extradural and subdural hematoma. The sensitivity for detecting intracranial hematoma including epidural, subdural, intracerebral and subarachnoid hematomas, of more than 2 cc was 97% (CI 93 - 99%) and the NPV was 100% (CI 99 - 100%). The sensitivity dropped for hematomas less than 2cc in volume to 84% (CI 71 - 92%) and the NPV was 99% (CI 98 - 99%). The sensitivity to detect bilateral hematomas was 94% (CI 74 - 99%).
The performance of currently tested NIRS device for detection of TICH was good and can be considered for triaging a patient requiring a CT scan of the head after injury. The NIRS device can efficiently detect traumatic unilateral hematomas as well as those bilateral hematomas where the volumetric difference is greater than 2cc.
我们报告了一种新开发的基于便携式近红外光谱(NIRS)的床旁检测设备CEREBO®用于检测创伤性颅内血肿(TICH)的结果。
纳入前往急诊室就诊且有头部受伤史的患者。使用CEREBO®和计算机断层扫描(CT)对他们进行连续检查,以确定是否存在TICH。
共对158名参与者和944个脑叶进行了扫描,经头部计算机断层扫描成像发现18%的脑叶存在TICH。由于头皮裂伤,33.9%的脑叶无法进行扫描。血肿的平均深度为0.8(标准差0.5)厘米,血肿的平均体积为7.8(11.3)立方厘米。CEREBO®将受试者分类为出血性或非出血性的总体敏感性、特异性、准确性、阳性预测值(PPV)和阴性预测值(NPV)分别为96%(可信区间90 - 99%)、85%(可信区间73 - 93%)、92%(可信区间86 - 96%)、91%(可信区间84 - 96%)和93%(可信区间82 - 98%);而将脑叶分类为出血性和非出血性时,敏感性、特异性、准确性、PPV和NPV分别为93%(可信区间88 - 96%)、90%(可信区间87 - 92%)、90%(可信区间88 - 92%)、66%(可信区间61 - 73%)和98%(可信区间97 - 99%)。检测硬膜外和硬膜下血肿时的敏感性最高,为100%(可信区间92 - 100%)。检测包括硬膜外、硬膜下、脑内和蛛网膜下腔血肿且体积超过2立方厘米的颅内血肿时,敏感性为97%(可信区间93 - 99%),NPV为100%(可信区间99 - 100%)。对于体积小于2立方厘米的血肿,敏感性降至84%(可信区间71 - 92%),NPV为99%(可信区间98 - 99%)。检测双侧血肿的敏感性为94%(可信区间74 - 99%)。
目前测试的用于检测TICH的NIRS设备性能良好,可考虑用于对受伤后需要进行头部CT扫描的患者进行分诊。该NIRS设备能够有效检测创伤性单侧血肿以及体积差异大于2立方厘米的双侧血肿。